Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-07-27 5:15 pm Sale | 13D | Neoleukin Therapeutics, Inc. NLTX | Redmile Group LLC | 2,912,228 6.6% | -118,338![]() (-3.90%) | View |
2023-06-28 5:15 pm Purchase | 13D | IGM Biosciences, Inc. IGMS | Redmile Group LLC | 3,291,092 9.9% | 257,595![]() (+8.49%) | View |
2023-06-21 5:15 pm Purchase | 13D | MedAvail Holdings, Inc. MDVL | Redmile Group LLC | 124,507,268 73.1% | 65,312,868![]() (+110.34%) | View |
2023-06-15 5:15 pm Unchanged | 13D | Augmedix, Inc. AUGX | Redmile Group LLC | 20,246,320 44.7% | 0 (Unchanged) | View |
2023-06-13 5:15 pm Sale | 13D | IGM Biosciences, Inc. IGMS | Redmile Group LLC | 3,033,497 10.3% | -343,593![]() (-10.17%) | View |
2023-05-04 5:15 pm Unchanged | 13D | Augmedix, Inc. AUGX | Redmile Group LLC | 20,246,320 44.7% | 0 (Unchanged) | View |
2023-04-21 5:15 pm Purchase | 13D | Augmedix, Inc. AUGX | Redmile Group LLC | 20,246,320 44.7% | 4,375,195![]() (+27.57%) | View |
2023-04-19 5:15 pm Purchase | 13D | Fate Therapeutics, Inc. FATE | Redmile Group LLC | 15,071,096 14.9% | 2,077,208![]() (+15.99%) | View |
2023-03-14 5:32 pm Purchase | 13D | MedAvail Holdings, Inc. MDVL | Redmile Group LLC | 59,194,400 56.5% | 12,520,256![]() (+26.82%) | View |
2023-02-14 4:32 pm Sale | 13G | Stereotaxis, Inc. STXS | Redmile Group LLC | 7,097,616 8.8% | -210,709![]() (-2.88%) | View |
2023-02-14 4:32 pm Sale | 13G | Scholar Rock Holding Corporation SRRK | Redmile Group LLC | 5,501,389 9.9% | -29,611![]() (-0.54%) | View |
2023-02-14 4:31 pm Purchase | 13G | HOOKIPA Pharma Inc. HOOK | Redmile Group LLC | 5,460,768 9.9% | 2,688,632![]() (+96.99%) | View |
2023-02-14 4:29 pm Sale | 13G | Achilles Therapeutics plc ACHL | Redmile Group LLC | 1,608,089 3.9% | -480,000![]() (-22.99%) | View |
2023-02-14 4:29 pm Purchase | 13G | Zymeworks Inc. ZYME | Redmile Group LLC | 6,175,918 9.8% | 100,000![]() (+1.65%) | View |
2023-02-14 4:29 pm Sale | 13G | Repare Therapeutics Inc. RPTX | Redmile Group LLC | 2,684,396 6.4% | -105,100![]() (-3.77%) | View |
2023-02-14 4:28 pm Purchase | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group LLC | 3,878,599 8% | 795,098![]() (+25.79%) | View |
2023-02-14 4:27 pm Purchase | 13G | Kymera Therapeutics, Inc. KYMR | Redmile Group LLC | 2,673,837 4.9% | 86,107![]() (+3.33%) | View |
2023-02-14 4:27 pm Purchase | 13G | Krystal Biotech, Inc. KRYS | Redmile Group LLC | 1,896,645 7.4% | 75,747![]() (+4.16%) | View |
2023-02-14 4:25 pm Sale | 13G | Entrada Therapeutics, Inc. TRDA | Redmile Group LLC | 1,854,108 5.9% | -100,312![]() (-5.13%) | View |
2023-02-14 4:23 pm Purchase | 13G | Akero Therapeutics, Inc. AKRO | Redmile Group LLC | 2,632,912 5.6% | 1,030,627![]() (+64.32%) | View |